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INTRODUCTION
Exogenous fatty acids and fatty acid derivatives influence a
wide variety of cellular processes including fatty acid and phos-
pholipid synthesis, organelle inheritance, vesicle fusion, pro-
tein export and modification, enzyme activation or deactiva-
tion, cell signaling, membrane permeability, bacterial
pathogenesis, and transcriptional control (13, 25, 49, 92, 134).
The processes governing the transport of fatty acids from the
extracellular milieu across the membrane are distinct from
those underpinning the transport of hydrophilic substrates
such as sugars and amino acids. Investigations into fatty acid
transport must address three central issues, which are unique
to this process: (i) the low solubility of fatty acids under aque-
ous conditions; (ii) the physical and chemical parameters of
fatty acids, which allows them to readily partition into a lipid
bilayer; and (iii) the identification of membrane-bound and
membrane-associated proteins, which are likely to play pivotal
roles in this process. In addition, diversity of lipid and protein
species in various biological membranes must be a central
consideration for investigations directed at defining the bio-
chemical mechanisms governing fatty acid transport.
The transport of exogenous long-chain fatty acids into the
cell is a highly regulated process, suggesting protein involve-
ment (58, 59, 62, 95). Cell types with high levels of fatty acid
metabolism (either degradation or storage) transport exoge-
nous fatty acids at higher apparent rates than do to those with
low levels of lipid metabolism (1–3, 52, 75). In a number of cell
types the process of fatty acid transport is inducible and com-
mensurate with the expression of specific sets of proteins
thought to participate in this process (9, 16, 17, 48, 49, 64). The
process of fatty acid transport is protease sensitive and can be
blocked through protein modification and the use of specific
antibodies. Furthermore, fatty acid transport can be disrupted
by the introduction of specific mutations in genes encoding
membrane-bound and membrane-associated proteins that are
likely to be involved in this process (14, 26, 27, 69, 127, 128,
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137). Since fatty acids can readily partition into and flip be-
tween the two surfaces of a membrane, the roles played by
these proteins in this process present something of a challenge.
For example, these proteins may function to regulate fatty acid
transport by contributing a specific activity at the levels of
fatty acid delivery to the membrane (binding), transmembrane
movement (or flip), or downstream metabolism. The use of
genetically tractable systems (Escherichia coli and Saccharomy-
ces cerevisiae) provides the genetic and biochemical tools nec-
essary to discern how these proteins function to facilitate long-
chain fatty acid transport.
FATTY ACIDS AND BIOLOGICAL MEMBRANES
The process of fatty acid transport across a membrane pro-
ceeds through five kinetically distinct phases defined as steps 1
to 5 (Fig. 1). From the standpoint of thermodynamic consid-
erations, steps 2 and 4 are reversible and simply involve the
transfer of the fatty acid into or out of the membrane. The
binding of exogenous free fatty acids into the membrane (step
2) is fast and exhibits saturation kinetics, which is dependent
on the number of fatty acid binding sites within the membrane
(on both leaflets). The number of fatty acid binding sites may
be an inherent property of the membrane alone or in combi-
nation with specific proteins that enhance this process. The
rate at which this step occurs is also dependent on the equi-
librium kinetics between the fatty acid in the bound state and
in the free state (step 1). Step 3 involves the transmembrane
movement of fatty acids from the exoplasmic face of the mem-
brane to the cytoplasmic face. For fatty acids in the uncharged
form (or protonated), most thermodynamic data suggest that
this step is very fast (t1/2  ms; [85]), although there is one
report suggesting that this step is rate limiting (89). There is
general consensus that the transmembrane flip of fatty acid
anions is slow (t1/2  2 s [85–88]). Using both model and
biological membranes, Hamilton and colleagues have shown
uncharged fatty acids flip between the exoplasmic face and the
cytoplasmic face of the membrane thereby obviating the need
for a specific protein to promote transmembrane movement
(65–68, 85–88, 138). In addition, there are several thermody-
namic studies which demonstrate that the movement of fatty
acids between the two membrane surfaces is a diffusive process
(65, 138). Step 4 involves the movement of fatty acids out of
the membrane, and, while this can occur spontaneously, it is
likely to be protein dependent and influenced by downstream
metabolism (see below). Step 1 represents the equilibrium
between fatty acid in a bound form and a free form. The bound
form of the fatty acid may be part of a mixed micelle, as would
be case in the intestine or in a protein-bound form as in a
capillary bed. Step 5 is linked to the intracellular metabolism,
which drives this process forward. This may involve the binding
of fatty acids to intracellular fatty acid binding proteins or may
involve downstream metabolism, which includes complex lipid
and triglyceride synthesis and -oxidation. It is envisioned that
three fundamental steps represent potential sites for protein
involvement in the process of fatty acid transport: (i) fatty acid
delivery to the membrane (steps 1 and 2), (ii) the transmem-
brane flip of fatty acids (particularly for fatty acid anions) (step
3), and (iii) the movement of fatty acids out of the membrane
prior to metabolism (steps 4 and 5).
As noted above, the binding and transmembrane flip of fatty
acids to and across the membrane is a rapid process, particu-
larly for uncharged fatty acids (87). It is clear that the trans-
membrane flip of fatty acids is a fundamental biophysical pa-
rameter that must be considered in defining the mechanism of
fatty acid transport, but this process is not equivalent to diffu-
sion. If diffusion is the fundamental driving force behind fatty
acid transport, the rate will be slow and essentially uniform for
all cell types. There is abundant evidence showing that differ-
ent cell types transport exogenous fatty acids at differing rates,
FIG. 1. Steps in fatty acid transport. As detailed in the text, this process is divided into five discrete steps, which can be kinetically defined (steps
1 to 5). Sites of potential protein involvement are highlighted by the thick arrows: fatty acid delivery to the membrane (steps 1 and 2), fatty acid
translocation across the membrane (step 3), and fatty acid abstraction or removal from the membrane (steps 4 and 5).
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which implies that proteins must necessarily be involved in this
process. The questions of how and at which step in the process
proteins are involved represent the experimental challenge.
Fatty Acid Transport Defined
Given that fatty acids bind to and flip between the two
membrane leaflets, it is imperative to define the fatty acid
transport process. The five steps described above for fatty acid
transport are consistent with both protein and diffusional com-
ponents. For the purposes of discussion, fatty acid transport is
defined as the net movement of the fatty acid from the outside
of the cell to the inside of the cell — or, more simply stated, the
movement of the fatty acid from the extracellular space into
the intracellular cytosolic compartment. Fatty acid transport
cannot be defined simply in terms of the flip of the fatty acid
from one leaflet of the membrane to the other, although this is
a central component of the overall process.
The focus of this review is the net movement of exogenous
fatty acids across the membrane, with a specific focus on the
role of fatty acid transport proteins and fatty acyl coenzyme A
(CoA) synthetases (FACS; fatty acid CoA ligase [AMP form-
ing] [EC 6.2.1.3]). There is considerable evidence showing that
the fatty acid transport proteins FadL (from gram-negative
bacteria) and Fat1p (the yeast orthologue of mammalian fatty
acid transport proteins [FATP]) function in concert with FACS
as components of a fatty acid transport apparatus, which re-
sults in concomitant transport and activation to CoA thioesters
by a process described as vectorial esterification.
MODEL SYSTEMS TO INVESTIGATE FATTY
ACID TRANSPORT
The use of two model systems to investigate the process of
fatty acid transport has provided fundamental insights into the
underlying biochemical mechanism of fatty acid transport.
Fatty acid transport is a saturable process in both E. coli and S.
cerevisiae; in addition, specific proteins which participate in this
process have been identified and characterized (18–29, 48–50,
54, 55, 77, 78, 93, 94, 138, 140, 141). Specific mutant strains of
E. coli and S. cerevisiae have been identified that are unable to
accumulate exogenous fatty acids, making these genetically
tractable model system excellent models to investigate the bio-
chemical principles essential to this process (25, 26, 92, 93, 137,
140). These different mutations result in specific and distinctive
phenotypes, which have allowed the identification of individual
protein components of their respective fatty acid transport
systems.
Genetic Foundations of Fatty Acid Transport
Microbial model systems are particularly useful to investi-
gate complex metabolic processes, since screens can be devel-
oped to select for mutations that confer specific phenotypes
directly related to that process. In the context of fatty acid
transport and activation in bacterial and yeast systems, mutant
strains defective in both fatty acid transport and/or fatty acid
activation have been identified that result in specific and dis-
tinguishing phenotypes (e.g., see references 23, 27, 55, 93, 94,
137, and 140).
The seminal work of Peter Overath in the late 1960s de-
scribed the fatty acid degradation (fad) regulon of E. coli (110).
These studies demonstrated that this regulon contains genes
involved in fatty acid activation and -oxidation and are under
coordinate regulation by a common transcription factor. A
central tenet of this work was the proposal that fatty acid
transport into the cell was tightly linked to FACS-mediated
fatty acid activation to the CoA ester. Furthermore, these
investigators showed that FACS was required for mediating
the induction of the genes of the fad regulon (110). This en-
zyme was both membrane associated and cytosolic, suggesting
that it moves into the membrane in response to a specific
signal. This early work suggested that this process was analo-
gous to vectorial phosphorylation, and the researchers coined
the term “vectorial acylation” to describe this process (110).
These early studies relied on classical bacterial genetics to
identify and map the genes involved in fatty acid activation and
degradation. Subsequent studies using molecular genetics have
expanded our understanding of these coordinately regulated
genes. Included in these later studies include those which iden-
tified the gene for the outer membrane-bound fatty acid trans-
porter (FadL) and demonstrated that long-chain fatty acyl
CoA is the effector molecule regulating the DNA binding ac-
tivity of the transcription factor FadR (44, 47, 132, 133). A
recent review by DiRusso et al. (49) provides a complete dis-
cussion of the fad regulon in E. coli and specific information on
the coordinate regulation of the genes involved in fatty acid
biosynthesis and fatty acid import, activation, and -oxidation
by FadR.
The fatty acid transport system in E. coli is presumed to be
common to gram-negative bacteria. A number of FadL and
FACS orthologues have been identified both experimentally
and by sequence comparisons (e.g., see reference 49). Most
notable are those described in Enterobacter cloacae and Hae-
mophilus influenzae (112, 135). An orthologue of the FACS
FadD has been experimentally defined in Mycobacterium tu-
berculosis (113).
More recently, a second model system, S. cerevisiae, has been
used to investigate the process of fatty acid transport in eu-
karyotic cells. Yeast requires exogenous unsaturated long-
chain fatty acids when grown under anaerobic conditions due
to the O2 requirement of 
9 fatty acid desaturase (126). In
addition, a conditional auxotrophy for exogenous long-chain
fatty acids occurs when fatty acid synthase is blocked using the
antibiotic cerulenin (54, 77, 78). Under both of these condi-
tions, mutants have been selected that are unable to grow
despite addition of long-chain fatty acids to the growth media.
This approach has been used to identify and characterize two
genes encoding two isoforms of FACS (FAA1 and FAA4),
which are involved in the activation of exogenous long-chain
fatty acids (51, 55, 77, 78, 90, 91), and one gene that encodes
the yeast orthologue of the mammalian fatty acid transport
protein (FAT1) (50, 54, 140).
PROTEINS IMPLICATED IN FATTY ACID TRANSPORT
A number of proteins which are hypothesied to play pivotal
roles in fatty acid transport have been identified and charac-
terized in both prokaryotic and eukaryotic cell types (Table 1).
On the basis of current understanding, the process of fatty acid
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transport is governed by two general mechanisms: (i) direct
fatty acid transport across the membrane and (ii) fatty acid
transport coupled to esterification to CoA thioesters. The can-
didate fatty acid transporters FAT and FABPpm appear to
contribute to this process via the first mechanism, while FATP
and FadL appear to operate in concert with FACS through the
second mechanism.
Fatty Acid Translocase
The first candidate eukaryotic fatty acid transport protein to
be identified was fatty acid translocase (FAT) (1–5, 12, 37, 75).
This 85,000 Mr protein was selected on the basis of its ability to
bind the fatty acid analogue sulfo-N-succinimidyl-oleate (SSO)
and the anion inhibitor 4,4-diisothiocyanostilbene-2,2-disul-
fonate (DIDS) (1, 70). Analysis of a cDNA clone of the gene
encoding FAT revealed that it is a 472-amino-acid protein with
a predicted molecular weight of 52,466 and is the rat homo-
logue of CD36, a glycoprotein first described in human plate-
lets and lactating mammary epithelium (4). FAT/CD36 has
been found in myocardial membranes, where it is also impli-
cated in the transmembrane transport of long-chain fatty acids
(106, 129, 130). This protein is a member of a broad family of
scavenger receptors and has been reported to act as a receptor
for thrombospondin, collagen, oxidized low-density lipoprotein
(LDL), anionic phospholipids, and Plasmidium falciparum in
addition to fatty acids (reviewed in reference 4). There is some
indication that CD36 deficiency contributes to the etiology of
hereditary hypertrophic cardiomyopathy (106, 130). Genetic
linkage studies suggest that a deficiency of FAT/CD36 is asso-
ciated with hypertriglyceridemia and hyperinsulinemia in the
spontaneously hypertensive rat (SHR) (6, 69). FAT/CD36 may
also facilitate the transduction of signals responsible for the
stimulation of enzymes catalyzing the conversion of arachi-
donic acid into different bioactive metabolites (4). In geneti-
cally obese (ob/ob) mice FAT mRNA levels are 15-fold higher
in liver and 60 to 80% higher in adipose tissue of ob/ob mice
than of their control littermates, (96) and FAT is induced by
lipids and peroxisomal proliferator activated receptor agonists
(101, 107, 117). More recent data have shown that CD36 is
recruited to the membrane from intracellular sites in response
to insulin (31). The most informative data on FAT/CD36 came
from studies of transgenic overexpressing and knockout mice.
The overexpression of FAT/CD36 in transgenic (MCK-CD36)
mice results in slightly lower body weight than that of control
littermates, reduced levels of triglycerides (LDL fraction), and
elevated levels of circulating fatty acids (73). Mice with engi-
neered deletions in the gene encoding FAT/CD36 are viable
yet have a significant decrease in binding and uptake of oxi-
dized LDL in peritoneal macrophages. These animals also
have significant increases in fasting levels of cholesterol (high-
density lipoprotein [HDL] fraction), nonesterified free fatty
acids, and triacylglycerol (LDL fraction) (37, 56). Each of these
phenotypes is consistent with alteration in lipid-trafficking
pathways. There is some information which suggests that FAT
may function in concert with the intracellular fatty acid binding
proteins (FABP). If this is indeed the case, FATP may function
as an intracellular sink for fatty acids following transport and
thus act to drive their net accumulation in the cell (4).
Fatty Acid Binding Protein—Membrane Bound
A second putative fatty acid transporter identified in mam-
malian cells, FABP—membrane bound (FABPpm), is identical
to mitochondrial aspartate amino transferase (mAspAT) (14,
17, 76, 122–125). NIH 3T3 fibroblasts transfected with a full-
length mAspAT cDNA under the control of the Zn2-induc-
ible metallothionein promoter express FABPpm in the pres-
ence of Zn2 (17). Expression correlates with a commensurate
increase in oleate uptake, and oleate uptake can be selectively
inhibited by antisera to FABPpm (76, 123, 125). More recently,
this protein has been identified in the placenta, where it is
proposed to participate in the uptake of long-chain and poly-
unsaturated fatty acids fatty acids required for fetal develop-
ment (32–34). FAT/CD36 and FATP are also expressed in the
placenta, perhaps indicating some type of cooperative interac-
tion between these three proteins (e.g., see reference 52).
The role of FABPpm in long-chain fatty acid transport is,
however, somewhat controversial. Intestinal epithelial cells
take up long-chain fatty acids by a saturable process and ex-
press FABPpm. In this case, pretreatment of these cells with
anti-FABPpm sera does not inhibit long-chain fatty acid up-
take, arguing that, at least in this cell type, there is a distinct
component involved in the transport process (131). In another
study, Xenopus laevis oocytes were injected with poly(A)
RNA isolated from liver cells and an increase in long-chain
fatty acid transport could be measured, suggesting that a pro-
tein(s) expressed from the cDNA was responsible for the ap-
parent increase in transport. However, when the cDNA for
mAspAT (FABPpm) was injected alone, there was no increase
TABLE 1. Proteins Involved in long-chain fatty acid transport
Protein Method of identification Features Reference(s)
FAT-CD36 Affinity labeling with sulfo-N-succinimidyl-oleate 85,000 Mr plasma membrane-bound glycoprotein;
also serves as a receptor of oxidized LDL
5, 70
FATPpm Oleate affinity chromatography Identical to mitochondrial aspartate
aminotransferase
17, 122
FATP Expression cloning Plasma membrane-bound protein; has intrinsic
very-long chain FACS activity; multiple
isoforms
74, 115
FadL Genetic knockout; functional studies on purified
protein
45,000 M, outer membrane protein restricted to
gram-negative bacteria
108
FACS Genetic knockout; expression cloning; functional
studies on purified enzyme
Widely distributed (including isoforms) with an
Mr of 65,000; functions to activate exogenous
fatty acids concomitant with transport
55, 110
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in long-chain fatty acid uptake, although the protein was de-
tected (57).
Fatty Acid Transport Protein
In 1992, two mouse proteins were identified using expres-
sion-cloning techniques, which, following transfection of Cos7
cells, resulted in an increased level of fluorescent fatty acid
accumulation. The first was FATP, and the second was FACS
(see below) (115). The use of expression cloning demonstrated
a direct physiological role for both of these proteins in the net
accumulation of fatty acids across a biological membrane. A
number of different isoforms of FATP have subsequently been
identified experimentally in mice, rats, humans, and yeast (e.g.,
mmFATP1, through mmFATP6 in mice) (54, 61, 74, 119–121).
Members of the FATP family have also been identified exper-
imentally or by sequence comparisons in nonmammalian sys-
tems including Caenorhabditis elegans, Drosophila melano-
gaster, S. cerevisiae, and M. tuberculosis (54, 74). The first
mouse isoform identified (mmFATP1) has 646 amino acid
residues and an apparent molecular weight of 63,000. Hydrop-
athy profiles predict that mmFATP1 contains one to four
membrane-spanning segments; recent experiments employing
epitope tagged forms have confirmed the presence of at least
one transmembrane domain (95). Immunofluorescence studies
of epitope-tagged mmFATP1 support the prediction this is an
integral membrane protein localized, at least in part, to the
plasma membrane (95).
The yeast FATP orthologue, Fat1p, has 35% sequence iden-
tity to mmFATP1 and mmFATP4 (50, 54, 74). Fat1p, like
several mmFATP isoforms, plays a role in the transport of
long-chain fatty acids across the plasma membrane and in the
activation of very long-chain fatty acids (36, 50, 136). Two
subdomains within these proteins, in particular, have a signif-
icant level of identity (70 to 80%), which serves as distinguish-
ing sequence elements or motifs (Fig. 2): (i) the ATP-AMP
binding motif (common to all adenylate-forming enzymes) and
(ii) the FATP-VLACS motif, which may be involved in con-
tributing to fatty acid specificity (and generally is restricted to
the FATP and very long-chain acyl-CoA synthetase [VLACS]
families). Some sequence identities within these motifs (par-
ticularly the ATP-AMP motif) are also shared among the
greater superfamily of FACSs (see below). The finding these
proteins belong to the superfamily of adenylate-forming en-
zymes was noted in the initial characterization of Fat1p, which
suggested an enzymatic activity (54). Indeed, subsequent stud-
ies have demonstrated that increased expression of three iso-
forms of the murine FATP (mmFATP1, mmFATP2, and
mmFATP4) and yeast Fat1p results in increased VLACS ac-
tivities (36, 38, 50, 71, 72, 136, 140). Data from the Schaffer
laboratory has shown an mmFATP1 allele carrying a single
amino acid substitution in the predicted ATP-AMP binding
region fails to transport fatty acids (127, 128). One interpreta-
tion of these data is that the formation of an acyl-adenylate
intermediate is required for transport.
The Long-Chain Fatty Acid Transport Protein FadL
Of the proteins characterized to date, only the long-chain
fatty acid transport protein FadL, found in gram-negative bac-
teria, fulfills all the criteria that defines an integral membrane-
bound fatty acid transporter. (i) FadL is localized in the outer
membrane, where it is proposed to span the membrane 20
times and form a -barrel specific for the transmembrane
movement of long-chain fatty acids (42). (ii) Bacterial strains
with a deletion of the fadL gene cannot grow on long-chain
fatty acids as a sole carbon and energy source and cannot
transport long-chain fatty acids across the cell envelope, yet
FIG. 2. Domain organization of the FATP family of proteins. (A) Amino acid sequence alignments of the ATP-AMP motif (common to all
members of the adenylate-forming superfamily of enzymes) and the FATP-VLACS motif (restricted to the FATP family) from Fat1p and the six
murine FATP orthologues. (B) Cartoon showing the approximate positions of the two elements of the ATP-AMP (white rectangles) and the
FATP-VLACS (black rectangle) motifs in the FATP family of proteins. aa, amino acids.
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they retain their ability to -oxidize long-chain fatty acids in
vitro (18, 99, 108). (iii) Mutational analyses have defined spe-
cific amino acid residues and subdomains of FadL, which dis-
tinguish the long-chain fatty acid binding and transport activ-
ities intrinsic to the protein (26, 93, 94). (iv) Fatty acid binding
to FadL has been demonstrated both in vivo and in vitro (24).
In the E. coli model system, fatty acid import not only is
dependent on the membrane-bound transporter, FadL, but
also requires the FACS, FadD (see below) (23, 49, 110). In this
regard, long-chain fatty acid transport is described as vectorial
acylation since the imported fatty acid becomes metabolically
trapped by esterification with Co A (110).
Fatty Acyl-CoA Synthetase
As noted above, the early work of Overath and colleagues
was consistent with the hypothesis that FACS plays a central
role fatty acid transport (110). FACS activity can be measured
in both membrane and soluble fractions in gram-negative bac-
teria, suggesting that this enzyme moves between the cytosol
and plasma membrane to facilitate the vectorial esterification
of exogenous fatty acids (110). Indeed, more recent studies
suggest that this enzyme is recruited to the plasma membrane,
but no information has been gleaned about the underlying
mechanism (99).
FACS catalyzes the formation of fatty acyl CoA by a two-
step process proceeding through the hydrolysis of ATP to yield
pyrophosphate. A central feature of catalysis is the formation
of an adenylated intermediate, which is enzyme bound (63). This
activation step involves the linking of the carboxyl group of the
fatty acid through an acyl bond to the phosphoryl group of AMP.
Subsequently, a transfer of the fatty acyl group to the sulfhydryl
group of Co A occurs, releasing AMP. The reaction proceeds via
a Bi-Uni, Uni-Bi Ter-molecular ping-pong mechanism with fatty
acid, ATP, and CoA all serving as substrates (63).
Fatty acid  ATP3 fatty acyl-AMP  PPi
Fatty acyl-AMP  CoA3 fatty acyl-CoA  AMP
The FACS, are part of a large family of proteins referred to
as the ATP-AMP binding proteins. A common feature of en-
zymes in this family is that they all form an adenylated inter-
mediate as part of their catalytic cycle. This group of enzymes
is diverse in catalyzing the activation of a wide variety of
carboxyl-containing substrates, including amino acids, fatty ac-
ids, and luciferin. Sequence comparison of members of the
ATP-AMP binding protein family has identified two highly
conserved sequence elements (YTSGTTGXPKGV and
GYGXTE) that comprise the ATP-AMP signature motif,
shared with the FATP family noted above (Fig. 3). The first
sequence is generally 125 to 130 residues upstream from the
second. A third, less highly conserved element that is thought
to contribute to ATP-AMP binding overlaps the FACS signa-
ture (70 to 75 residues downstream from the second), which is
involved in both catalysis and specificity of the fatty acid sub-
strate (see below).
A second, more highly conserved sequence element
DGWLHTGDIGXWXPXGXLKIIDRKK is common to all
FACSs but is not highly conserved in the larger family of
ATP-AMP binding proteins (Fig. 3). This sequence has been
defined as the FACS signature motif (27). There are a number
of notable features within the FACS signature motif. (i) This
region contains two invariant glycine residues (at positions 2
and 7) and a highly conserved glycine at position 16. Therefore,
it is reasonable to predict that this region adopts a similar
tertiary structure in all FACSs. (ii) This region contains an
additional six residues that are invariant in the FACSs: Trp at
position 3, Thr at position 6, Asp at position 8, Asp at position
22, Arg at position 23, and Lys at position 25. (iii) The con-
sensus sequence predicts an aspartic acid residue at position 1.
However, in the bacterial enzyme, this is an asparagine, and
conversion of the asparagine to alanine has no effect on en-
zyme activity, indicating that the presence of the carboxylate is
not crucial for activity. (iv) The residue in the fourth position
is hydrophobic and is either a leucine, a methionine, or phe-
nylalanine. (v) This region of the enzyme contains hydrophobic
residues (either leucine, isoleucine, or valine) at positions 4, 9,
FIG. 3. Domain organization of the FACS family of enzymes. (A) Amino acid sequence alignments of the ATP-AMP motif (common to all
members of the adenylate-forming superfamily of enzymes noted in Fig. 2) and the FACS motif (restricted to the FACSs) from FadD, yeast (Faa1p
and Faa4p), human, mouse, and rat. (B) Cartoon showing the approximate positions of the two elements of the ATP-AMP (white rectangles) and
FACS (black rectangle) motifs. aa, amino acids.
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18, 20, and 21. These residues, in addition to tryptophan res-
idues at position 3, may comprise part of a fatty acid binding
pocket. (vi) There is a preference for basic residues at positions
19 and 24 in addition to those at positions 22 and 25 (27).
Emerging evidence is consistent with the notion that FACS
also plays a pivotal role in fatty acid transport in eukaryotic
systems. In the expression cloning experiments that identified
mmFATP1, a second, independent (and often overlooked)
clone encoding FACS was also isolated, suggesting that this
enzyme is also a component of the fatty acid transport system
in murine adipocytes (115). In fact, in the original work de-
scribing mmFATP1, Schaffer and Lodish did suggest that these
two proteins function in concert to facilitate long-chain fatty
acid uptake by a process analogous to that defined for E. coli
FadL and FadD (115). More recent work has shown that
mouse FACS isoform 1 is localized at the plasma membrane,
suggestive of its role in activating exogenous long-chain fatty
acids (60). In yeast, there is a strict requirement for FACS
(Faa1p or Faa4p) in the fatty acid transport process (55, 141).
VECTORIAL ACYLATION: ONE MECHANISM
OPERATIONAL IN FATTY ACID TRANSPORT
In this review, we specifically focus on the fatty acid trans-
port systems that function through a coupled fatty acid trans-
port-activation mechanism referred to as vectorial acylation.
As detailed above, this mechanism is likely to be operational in
all eukaryotic and prokaryotic cell types, which allows this
process to be highly regulated to meet the needs of the cell.
For bacteria and yeast, current evidence suggests that this is
the predominant mechanism driving exogenous long-chain
fatty acid transport.
THE BACTERIAL PARADIGM
The cell envelope of gram-negative bacteria represents a
formidable barrier for long-chain fatty acids. It is composed of
two structurally and functionally distinct membranes (78, 79,
102–105, 111, 114). The outer membrane is composed of an
external layer of lipopolysaccharide and an internal layer of
phospholipid. The external lipopolysaccharide layer is refrac-
tory toward hydrophobic compounds, thereby providing a pro-
tective shield for the cell, while the internal phospholipid layer
is associated with a layer of peptidoglycan. Outer membrane
proteins involved in the acquisition of nutrients fall into three
general classes: (i) nonspecific porins, (ii) substrate-specific
porins, and (iii) high-affinity, substrate-specific transport pro-
teins (102–104). The inner membrane is a more typical phos-
pholipid bilayer and contains proteins involved in nutrient
transport, energy production, and phospholipid biosynthesis
(78, 79). The two membranes are separated by the aqueous
periplasmic space, which is rich in proteins (some of which
function in nutrient transport) and membrane-derived oligo-
saccharides (7, 8). For E. coli to utilize exogenous long-chain
fatty acids, these compounds must first traverse the three layers
of the cell envelope.
In E. coli, two genes are required for the transport of exog-
enous long-chain fatty acids: fadL, encoding the outer mem-
brane protein FadL, and fadD, encoding the inner membrane-
associated FACS FadD (Fig. 4) (49). Deletion of either fadL or
fadD results in an inability of cells to grow on minimal plates
containing fatty acids of any chain length. In cells harboring a
mutation in both fadL and fadR (encoding the fatty acid-re-
sponsive transcriptional regulator), cells grow on plates con-
taining medium-chain fatty acids but not long-chain fatty acids.
This implies that FadL is specific for long-chain fatty acids
while the E. coli FACS is involved in activating fatty acids of
different chain lengths (18, 21, 108). Studies of the purified
FACS FadD have borne this out: this enzyme can activate fatty
acids with chain lengths varying from C6:0 to C20:4, with the
highest specificity for C14:0 to C18:0 fatty acid substrates (82,
83). The periplasmic protease Tsp is also required for optimal
levels of transport, although its precise role in this process
remains undefined (10). There is also evidence supporting the
existence of a specific fatty acid/H cotransporter in the inner
membrane; the structural gene encoding this protein has not
been identified (81, 84).
Energetics of Fatty Acid Transport in
Gram-Negative Bacteria
The long-chain fatty acid transport system in E. coli is par-
tially shock sensitive, suggesting that a precise chemical com-
position (pH, periplasmic protein, etc.) is required, requires
ATP generated by either substrate-level or oxidative phosphor-
ylation, and requires the proton electrochemical gradient
across the inner membrane for maximal proficiency (11).
The transport of long-chain fatty acids requires ATP gener-
ated through substrate-level or oxidative phosphorylation. This
apparently reflects the ATP requirement of FACS as a com-
ponent of this transport apparatus. Many transport systems
that require ATP are protein-dependent ABC transporters,
which function together with a periplasmic binding protein, an
inner membrane-bound protein(s), and an ATPase protein.
The ATP requirement in the bacterial long-chain fatty acid
transport system is distinct and reflects the formation of a fatty
acyl adenylate intermediate during the catalytic cycle FACS
(63). The process of long-chain fatty acid transport in bacteria
is also linked to the proton electrochemical gradient across the
inner membrane. This is evidenced by an appropriate decrease
in long-chain fatty acid transport rates when cells are treated
with protonophores prior to assay.
The long-chain fatty acid transport system in E. coli requires
both intracellular ATP pools and an energized inner mem-
brane and thus has features common to both types of classi-
cally defined transport systems (11). Figure 4 illustrates a
model of how this transport system is energized. Long-chain
fatty acids traverse the outer membrane via FadL, pass through
the periplasmic space, and partition into the inner membrane.
If, as suggested Hamilton and coworkers (87), long-chain fatty
acids traverse the membrane via diffusion (flip) in the proton-
ated form, then the energized membrane may act to acidify the
periplasmic space, resulting in the protonated form of the
long-chain fatty acid. Once the long-chain fatty acid partitions
into the inner membrane, FACS functions to abstract these
compounds from the membrane, concomitant with activation
to CoA thioesters. The -oxidation of long-chain fatty acids
following activation provides the respiratory substrates re-
quired for the maintenance of an energized membrane and
intracellular pools of ATP and thus provides sufficient meta-
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bolic energy for the efficient uptake of exogenous long-chain
fatty acids across the cellular envelope.
The Fatty Acid Transporter FadL
The process of fatty acid transport in E. coli was originally
described in work characterizing the fadD gene, encoding
FACS (110). On the basis of kinetic data, these early studies
predicted that at least one additional protein is also involved in
the facilitated transport of long-chain fatty acids in E. coli.
Nunn and Simons identified and mapped the fadL gene, en-
coding the long-chain fatty acid transport protein FadL, con-
firming this prediction (108). Subsequent studies describing
the kinetics of fatty acid transport in E. coli are consistent with
the postulate that FadL is specifically involved in the transport
of long-chain fatty acids and requires the carboxylate of the
fatty acid for ligand binding (21, 100, 109). FadL is predicted to
span the membrane 20 times as antiparallel -strands forming
a -barrel (Fig. 5) (42).
How does FadL mediate long-chain fatty acid binding and
transport? Long-chain fatty acid binding to FadL is predicted
to result in a conformational change, thereby exposing the
transport channel and facilitating transport across the outer
membrane. Several mutations within fadL, including fadLH3,
have been identified, which suggest that this protein undergoes
conformational change on fatty acid binding (Fig. 5B) (93, 94).
The mechanism promoting the movement of fatty acids across
the outer membrane via the FadL channel is not known, but on
the basis of data generated from a collection of fadL mutants,
it is presumed to involve both hydrophobic and charged amino
acid residues within the carboxyl-terminal region of the protein
(94).
The Fatty Acyl-CoA Synthetase FadD
E. coli contains a single FACS (FadD) with broad chain
length specificity toward saturated, unsaturated, and polyun-
saturated fatty acids (82, 83). This enzyme is essential for the
activation of exogenous long-chain fatty acids destined for
-oxidation and plays an essential role in the regulation of the
transcription factor FadR. The E. coli FACS has considerable
similarities to other FACSs and, more broadly, to the super-
family of adenylate-forming enzymes. As noted above, this
family of enzymes contains two conserved sequence elements:
the ATP-AMP signature (involved in ATP binding) and the
FACS signature (involved in fatty acid binding and specificity)
(Fig. 3).
The E. coli FACS FadD contains two sequence elements,
which comprise the ATP-AMP signature motif (213YTGGTT
GVAKGA218 and 356GYGLTE361). A series of alanine substi-
tutions were generated corresponding to the ATP-AMP signa-
ture motif site to evaluate the role of this highly conserved
FIG. 4. Components and energetics underlying the transport of long-chain fatty acids (LCFA) across the cellular envelope of E. coli.
Long-chain fatty acids traverse the outer membrane by way of the specific transport protein FadL. Once they traverse the outer membrane, they
enter the periplasmic space, where they are protonated allowing them to partition into the inner membrane. The proton electrochemical gradient
across the inner membrane contributes the protons in the periplasmic space. FACS (FadD) responds to the intracellular pools of ATP and in a
primed form (FadD-ATP) is hypothesized to sense the free fatty acid [LCFA(H)] in the inner membrane. In the membrane-bound form, FadD
catalyzes the formation of long-chain fatty acyl-CoA (LCFacyl CoA), rendering the process of transport unidirectional. Respiratory substrates for
the generation of the electrochemical gradient across the inner membrane under conditions where cells are grown on long-chain fatty acids come
from ATP synthetase and -oxidation. Adapted from reference 11 with permission.
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region in enzyme function and fatty acid transport (137). Two
major classes of fadD mutants were identified, both of which
depressed enzyme activity: (i) those with 25 to 45% of wild-
type activity and (ii) those with 10% of wild-type activity or
less. The defect in the first class results in catalytic insufficiency,
although several mutant forms also have a reduced affinity for
ATP. Both classes of fadD mutations result in biochemical
phenotypes that also reduce or essentially eliminate the trans-
port of exogenous long-chain fatty acids, supporting the hy-
pothesis that FACS functions in the vectorial movement of
exogenous fatty acids across the plasma membrane by acting as
a metabolic trap resulting in the formation of acyl-CoA esters.
Alanine-scanning mutagenesis has allowed for the molecular
dissection of specific roles of the amino acid residues within
the FACS signature motif noted above. These studies demon-
strated that the FACS signature motif contains specific amino
acids essential for catalytic activity and specify the fatty acid
binding site within the enzyme (27). Three distinct classes of
fadD mutations were identified on the basis of growth charac-
teristics, FACS profiles using oleate, myristate, and decanoate
as substrates, and studies using purified wild-type and mutant
forms of the enzyme. (i) Only one substitution (fadDN431A)
resulted in wild-type FACS activity profiles (Fig. 3). (ii) Ten
mutations abolished or greatly diminished enzyme activity. (iii)
Seven mutations resulted in altering fatty acid chain length
specificity. The finding that specific mutations resulted in al-
tering fatty acid chain length specificity is consistent with the
hypothesis that this region of the enzyme is specifically re-
quired for fatty acid binding.
Subsequent studied have clearly shown that the region of the
enzyme corresponding to the FACS motif is involved in fatty
acid binding. The affinity-labeled long-chain fatty acid 9-p-
[3H]azidophenoxy nonanoic acid (APNA) specifically modifies
a region adjacent to and including the FACS signature of the
E. coli enzyme (28). This work provided the first experiment-
based data identifying the carboxyl-containing substrate bind-
ing domain within the adenylate-forming family of enzymes. As
noted below, the predicted structural model for the E. coli
FACS suggests that the FACS motif lies within a cleft sepa-
rating two distinct domains of the enzyme and is adjacent to a
region that contains the AMP-ATP signature motif, which,
together, are likely to represent the catalytic core of the en-
zyme.
Structural Considerations of FACS
While several members of the ATP-AMP binding protein
family have been crystallized and their structures have been
resolved, the structure of FACS has not yet been defined.
Using the crystallographic information for two enzymes con-
taining the ATP-AMP signature motif (firefly luciferase [39]
and the phenylalanine activating subunit [PheA] of gramicidin
synthetase 1 [40]), a three-dimensional model for the E. coli
FACS FadD has been proposed (Fig. 6) (28). This model
FIG. 5. Predicted topology and functional predictions of the of the long-chain fatty acid transport protein FadL. (A) Cartoon showing the 20
antiparallel -strands of FadL, which are presumed to form a fatty acid-specific -barrel within the outer membrane; noted are R93 and R384, which
are externally exposed, and the location of the insertion mutation fadLH3, a 2-amino-acid insertion in a periplasmic exposed loop that causes the
FadL channel to be in an open conformation. (B) Cartoon illustrating ligand-induced conformational change in FadL, thereby facilitating
long-chain fatty acid movement across the outer membrane. 1, FadL in a closed conformation; 2, FadL-specific binding of long-chain fatty acids
requires both the acyl chain and the carboxylate of the fatty acid; 3, long-chain fatty acid induced conformational change allowing the fatty acid
to traverse the membrane and enter the periplasmic space. Reprinted from reference 42 with permission.
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predicts that the region identified as the FACS signature,
which is hypothesized to specify fatty acid binding, forms a
,-turn- structure, which is on the same face of the enzyme
as elements that comprise the ATP-AMP signature motif and
are presumed to specify ATP binding. The region of the en-
zyme identified using affinity labeling identified a peptide, be-
ginning with P422, adjacent to and contiguous with the FACS
signature, confirming the hypothesis regarding the fatty acid
binding domain. On the basis of the predicted structure of this
enzyme, the region bound by -1 and -2 of the FACS signa-
ture motif contributes to a cavity that is likely to represent the
fatty acid binding site. On the basis of this information, it
seems likely that the region of FACS which includes the cleft
separating the two domains of the enzyme represents the cat-
alytic core of the enzyme. It is worth speculating that on ligand
(ATP and fatty acid) binding, the two domains of the enzyme
become juxtaposed to facilitate the formation of the fatty acyl
adenylate.
The conservation of residues within the two elements of the
ATP-AMP signature motif by all adenylate family members
indicates that these regions contribute to the binding of ATP
and/or to the formation of the enzyme adenylated reaction
intermediate, since ATP is the one substrate common to all
members. The crystal structure of firefly luciferase reveals that
the N-terminal domain comprises the major portion of the
molecule and consists of a distorted antiparallel -barrel and
two -sheets flanked on either side by -helices. Based on the
predicted three-dimensional model of the FACS FadD from E.
coli, the majority of these residues are clustered in a cleft
separating two domains of the enzyme (28). The crystal struc-
ture of PheA complexed with AMP shows an Mg2 bridge
between the invariant glutamate of the second sequence ele-
ment of the ATP-AMP signature and the O-1 phosphate of
AMP (40). Changing this glutamate to alanine in the FACS
FadD results in complete loss of enzyme activity, which then
results in an inability to transport long-chain fatty acids (137).
As noted above, many members of the adenylate-forming
family of enzymes contain conserved sequence elements that
also overlap the FACS signature sequence. Of particular note
is a highly conserved aspartate at position 438, which lies at the
beginning of the FACS signature. Using the crystal structure of
PheA complexed with AMP as a guide, is seems plausible this
residue functions to position the ribose ring of AMP. In PheA,
the carboxyl group of this aspartate forms specific H-bonding
interactions with the two hydroxyls of the ribose moiety of
AMP (40). A mutant form of the FACS FadD, FadDD438A, has
no acyl-CoA synthetase activity with oleate and decanoate as
substrates, in contrast to the native enzyme (27). These data
imply that Asp438 is critical for catalysis and contributes to fatty
acid substrate specificity. The loss of the carboxylate may affect
the orientation of contiguous residues, thereby modifying the
geometry of the binding cleft. Indeed, site-directed mutagen-
esis studies of the adenylate-forming enzyme TycA support the
hypothesis that a hydrogen bond donor is required at this
position to stabilize the nucleotide. In TycA, replacement of
the comparable Asp with Arg reduces ATP-PP1 exchange to
78% of the wild-type levels while replacement with Ser reduces
this activity by only 12% (35).
FATTY ACID TRANSPORT AND ACTIVATION IN YEAST:
EVIDENCE FOR A MULTICOMPONENT COMPLEX
As detailed above, fatty acid transport in yeast requires
Fat1p (the orthologue to the mammalian FATPs) and FACS
(either Faa1p or Faa4p). These data suggest that, as in the
bacterial system, the process of fatty acid transport is driven by
the esterification of fatty acids as a result of either Faa1p or
Faa4p. The role of Fat1p is, however, quite distinct from the
bacterial outer membrane protein FadL. Strains defective in
FAT1 have wild-type FACS activities, which is consistent with
the notion that the activity of Fat1p precedes that of either
Faa1p or Faa4p.
The phenotypes in yeast strains defective for fatty acid trans-
port are more complex than those defined in bacteria, in part
due to the difficulty of growing yeast on minimal fatty acid
plates. As noted above, two conditions exist where growth of
FIG. 6. (A) Model of the E. coli FACS developed using the Swiss-
Model Protein Modeling Server and visualized using MolScript. The
predicted structure begins with residue T213 of the native enzyme.
Residues that comprise the peptide modified with APNA and continu-
ing into the FACS signature motif are indicated (P422 to K455). 
denotes the predicted -helix upstream from the FACS signature mo-
tif; -1, -2, and -3 denote the , -turn- structure of the FACS
signature motif (Fig. 3); and L denotes the linker between the large
N-terminal and small C-terminal domains of the enzyme. The boxed
region denotes the -loop  structure that comprises the first sequence
element of the ATP-AMP signature motif, while the residue identified
by an asterisk is E361 (within the second sequence element of the
ATP-AMP signature motif), which is conserved in all adenylate-form-
ing enzymes. (B) -Carbon tracing of the FACS signature motif (N431
to K455) highlighting the ,-turn-structure, which is proposed to
contribute to the fatty acid binding pocket within the enzyme. Repro-
duced from reference 28 with permission.
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yeast requires supplementation of exogenous fatty acids to the
growth media, providing a screen to select for mutants defec-
tive in fatty acid transport and activation. The first involves
anaerobic conditions, where the cells require exogenous unsat-
urated long-chain fatty acids due to inactivity of the O2-requir-
ing 9 fatty acid desaturase. The second is a conditional aux-
otrophy when fatty acid synthase is inhibited with the antibiotic
cerulenin (51, 54). Using these screening conditions, three
genes have been identified as components of the fatty acid
transport system in S. cerevisiae. Strains defective in FAT1
(encoding Fat1p) or in both FAA1 and FAA4 (encoding the
FACSs Faa1p and Faa4p) are unable to grow under anaerobic
conditions or on media containing cerulenin, even with long-
chain fatty acid supplementation (54, 55).
Role of Fat1p
Disruption of FAT1 (encoding Fat1p) results in five pheno-
types expected for cells with restricted ability to import fatty
acids. These mutant cells fail to grow on media containing the
fatty acid synthesis inhibitor cerulenin even when the long-
chain fatty acid oleate is supplied in the growth media. These
cells are also unable to grow when cultured under hypoxic
conditions when they are auxotrophic for unsaturated fatty
acids. Yeast cells containing a FAT1 deletion fail to accumu-
late the fluorescent long-chain fatty acid analogue C1-
BODIPY-C12 and have a greatly diminished capacity to trans-
port exogenous long-chain fatty acids (Fig. 7). Furthermore,
the utilization of exogenous fatty acids in -oxidation and
phospholipid biosynthesis is also diminished in mutant cells by
comparison with wild type. These data attest to the physiolog-
ical importance of Fat1p in the transport of exogenous long-
chain fatty acids. As noted above, the deletion of FAT1 does
not result in decreasing FACS activities when decanoate, my-
ristate, and oleate are used as substrates (54).
Work by DiRusso et al. (50) has shown that yeast Fat1p and
murine FATP1 are functionally equivalent. Each of the mutant
phenotypes noted above is eliminated when the mutant strains
are transformed with either a clone encoding the yeast Fat1p
or an expression clone encoding the murine FATP.
In addition to playing a central role in fatty acid transport,
there are data showing that Fat1p is involved in very long-chain
(C22 to C26) fatty acid metabolism (29, 42, 136). Fat1p and
several other members of the FATP family have intrinsic very
long-chain FACS activity, suggesting that these enzymes are
involved in intracellular fatty acid trafficking and, more specif-
ically, in very long-chain fatty acid metabolism. Strains defi-
cient in FAT1, for example, accumulate very long-chain fatty
acids and have reduced very long-chain FACS activities. These
findings present something of a dilemma in how to specifically
reconcile both observations within the framework of yeast fatty
acid metabolism. The specificity of the fatty acid transport
system in yeast appears to be toward long-chain fatty acids as
opposed to very long-chain fatty acids. Given the rarity of very
long-chain fatty acids in the natural environment, it seems
unlikely that a cell would evolve an import system specifically
for these compounds. It is unknown whether the very long-
chain FACS activity intrinsic to Fat1p is required for fatty acid
import or whether these two activities are distinct. The current
understanding of this protein favors independent functions for
two reasons. First, the specificity of Fat1p-dependent import is
for long-chain fatty acid substrates, while Fat1p-dependent
FACS activity is for very long-chain substrates (50, 54). Sec-
ond, deletion of FAA1 encoding the major long-chain FACS
decreases fatty acid import nearly threefold, which suggests
that this enzyme is primarily responsible for activating fatty
acids from an exogenous source and therefore dictates the
specificity of the import system (55). As detailed below, there
is emerging evidence supporting the functional association of
Fat1p and Faa1p in mediating the regulated transport of ex-
ogenous long-chain fatty acids.
Directed Mutagenesis of FAT1 and Functional
Organization of Fat1p
As noted above, members of the FATP family have amino
acid similarities and identities to the FACSs and the greater
superfamily of adenylate-forming enzymes, the hallmark of
which is the ATP-AMP signature motif. The FATP protein
family is distinguished from the FACSs and other adenylate-
forming enzymes by containing additional sequence elements
common only to these proteins designated the FATP-VLACS
signature motif (Fig. 2). To test the hypothesis that regions of
sequence identity between the FATP family and the greater
FACS family define the common ATP-AMP motif and se-
quence identities common only to members of the FATP fam-
ily define the transport functions, a library of fat1 alleles with
alanine substitutions within each region have been generated
and characterized (Fig. 8) (140). The residues replaced with
alanine in the ATP-AMP signature motif included Y256, S258,
and T260. Two of the resultant mutant proteins, Fat1pY256A
and Fat1pT260A, had reduced VLACS activities, which corre-
lated with reductions in long-chain fatty acid transport. How-
ever, Fat1pS258A is unique because it has lost detectable
VLACS activity but retained the ability to transport long-chain
fatty acids, indicating that ATP binding and formation of the
acyl adenylate may be separated from the transport function,
while it is essential for catalysis. Additional alanine substitu-
tions were generated at F325, L353, N372, or T398 in Fat1p. Each
of these amino acids lies in areas conserved within the FATP
family but more divergent when compared with the long-chain
FACS family. These amino acid residues overlap the ATP-
AMP motif shown in Fig. 2. By comparison with the FACS
FadD, which has been more extensively characterized (27, 28),
these amino acid residues are likely to be positioned in the
nucleotide binding pocket of the protein. As expected, substi-
FIG. 7. Patterns of C1-BODIPY-C12 uptake in fat1 and wild-type
(FAT1) cells of S. cerevisiae. Reproduced from reference 50 with
permission.
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tution of each of these highly conserved residues resulted in
decreased VLACS activity. They also resulted in decreased
growth under selective conditions, which was correlated with
decreased long-chain fatty acid transport (140).
Regions within Fat1p that contain the FATP-VLACS motif
and sequences toward the carboxyl end of the protein are
highly conserved among members of the FATP and very long-
chain FACS families. These regions are likely to specify func-
tional domains for promoting fatty acid binding specificity and
fatty acid transport: functions that are unique and define this
family. Preliminary analyses of eight amino acid substitutions
constructed in Fat1p within these regions support this proposal
(140). Three of the residues replaced with alanine were abso-
lutely conserved between yeast Fat1p and the five murine
FATP isoforms: D508, D522, and R523 (140). Of these,
Fat1pD522A and Fat1pR523A had greatly reduced VLACS and
transport activities. Fat1pD508A was unique in that it retained
the transport function but lost VLACS activity. Five other
targeted amino acids were characterized because they were
identical in Fat1p, mmFATP1, and mmFATP4 but were dif-
ferent in one or more of the other murine FATP isoforms.
Phenylalanine is found in mmFATP2, mmFATP3, and
mmFATP5 at the position corresponding to Y504 of Fat1p (and
mmFATP1 and mmFATP4). Replacement of Y504 with ala-
nine reduced but did not eliminate any of Fat1p functions. Y519
(of Fat1p) is conserved in all murine isoforms except
mmFATP5, which contains a histidine residue. Replacement
of this residue with alanine severely decreased all functions
associated with Fat1p. F528 and L669 are conserved in all iso-
forms of mmFATP but mmFATP3, which contains isoleucine
and arginine at the respective positions. Replacement of either
of these residues in Fat1p (Fat1pF528A and Fat1pL669R) elim-
inated fatty acid transport activity, and while VLACS activity
was reduced, it was not eliminated. The results obtained for
these two mutants and for Fat1pS258A and Fat1pD508A are very
valuable because they demonstrate that the fatty acid transport
activity could be experimentally separated from the VLACS
activity.
The Fatty Acyl-CoA Synthetases Faa1p and Faa4p
It is difficult to dissociate fatty acid transport from metabolic
utilization. In bacteria, yeast, and higher eukaryotes, one
mechanism promoting fatty acid transport is proposed to in-
volve the coupling of transport with activation to CoA thio-
esters. The concomitant transport and activation result in ac-
tivated fatty acids, which are metabolized very quickly. As
noted above, this is clearly the case in the bacterial paradigm.
In yeast and higher eukaryotes, the same fundamental process
is likely to be operational. The FACSs encoded within yeast
FAA1 or FAA4 (Faa1p and Faa4p, respectively) play a central
role in fatty acid transport (55).
As detailed above, the process of long-chain fatty acid trans-
port is likely to include diffusion of the fatty acid across the
membrane, where there is flip of the uncharged fatty acid from
the outer leaflet to the inner leaflet (65). However, it is clear
from a number of studies that there is a need for a sink to
establish a concentration gradient from the outside to the
inside or the fatty acid would remain trapped in the membrane
(4, 62, 65, 89). In yeast, the formation of the acyl-CoA thioester
catalyzed by Faa1p or Faa4p represents the sink that governs
transport.
In yeast, fatty acid import is restricted in strains carrying a
deletion in FAT1 as well as in strains carrying deletions in both
FAA1 and FAA4. The fat1 and faa1 faa4 strains have
indistinguishable phenotypes when grown on YPD containing
oleate and cerulenin or under anaerobic conditions (54, 55). In
addition, strains carrying deletions in both FAA1 and FAA4 fail
to accumulate C1-BODIPY-C12 (Fig. 9). This information im-
plies that minimally Fat1p and either Faa1p or Faa4p are
components of a metabolic system linking fatty acid import and
utilization. Several studies have shown that Faa1p, as opposed
to Faa4p, is the predominant FACS involved in this process.
Four notable results have led to this conclusion. (i) Faa1p
functions as the major FACS within the cell during the loga-
rithmic phase growth. (ii) Fatty acid import is markedly re-
duced in Faa1p-deficient cells. (iii) Formation of oleoyl-CoA
from oleate supplied exogenously is reduced in the faa1
strains. (iv) The levels of -oxidation are severely depressed in
strains containing a deletion in FAA1 compared to the levels in
the wild type and strains containing a deletion in FAA4.
Interaction of Fat1p and FACS
The studies described above show that exogenous long-chain
fatty acids enter the yeast cell by a process that requires Fat1p
and either the FACS Faa1p or Faa4p (54, 55). Prior to meta-
bolic utilization, exogenous fatty acids must be activated to
their CoA thioesters. In yeast, the FACS Faa1p accounts for
approximately 95% of the myristoyl- and palmitoyl-CoA syn-
thetase activity while Faa4p accounts for approximately 2% of
the activity toward these substrates (77, 90). Deletion of FAT1
or FAA1 and FAA4 impairs growth on media supplemented
with oleate and cerulenin and under anaerobic conditions.
Furthermore, deletion of both FAA1 and FAA4 prevents the
incorporation of exogenously supplied fatty acids into phos-
FIG. 8. Directed mutagenesis of FAT1. Asterisk indicate the resi-
dues within the ATP-AMP and FATP-VLACS signature motifs (Fig.
2) within Fat1p subjected to mutagenesis. Highlights of these mutants
(140) are presented in the text.
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pholipids while deletion of FAT1 reduces the rate of incorpo-
ration (55). Under conditions where Faa1p is inactive or ex-
pression of FAA1 is reduced, Faa4p partially compensates for
the loss of function (55, 77, 90).
More recent molecular genetic and biochemical studies fur-
ther define the functional and physical interactions between
these Fat1p and Faa1p or Faa4p. Multicopy extragenic sup-
pressors were selected in strains carrying deletions in FAA1
and FAA4 or FAA1 and FAT1. In the first strain, plasmids
encoding FAA1, FAT1, and FAA4 were identified, while in the
second strain, plasmids encoding FAA1 and FAT1 were iden-
tified. In the latter case, multicopy FAA4 identified in the
faa1 faa4 strain could not suppress the growth defect in the
faa1 fat1 strain, indicating that some essential functions of
FAT1 cannot be performed by this FACS. Chromosomally
encoded FAA1 does not suppress the growth deficiency of a
fat1 faa1 strain, nor does chromosomally encoded FAT1
complement the growth defect of a faa1 faa4 strain, indi-
cating that these proteins play distinct roles in the fatty acid
transport process (141). When expressed from a 2	m plasmid,
Fat1p has significant oleoyl-CoA synthetase activity, which in-
dicates that vectorial esterification and metabolic trapping is
the driving force behind import. Evidence of a physical inter-
action between Fat1p and Faa1p comes from three indepen-
dent biochemical approaches (141). (i) a C-terminal peptide of
Fat1p deficient in fatty acid transport exerts a dominant neg-
ative effect against long-chain FACS activity. (ii) Protein fu-
sions employing Faa1p as the bait and portions of Fat1p as the
trap are active when tested using the yeast two-hybrid system.
(iii) Coexpressed, differentially tagged Fat1p and Faa1p or
Faa4p are coimmunoprecipitated (Fig. 10). Collectively, these
data support the hypothesis that fatty acid import by vectorial
acylation in yeast requires a multiprotein complex which con-
sists of Fat1p and Faa1p or Faa4p (Fig. 11).
FATTY ACID TRANSPORT AND
BIOLOGICAL MEMBRANES
The transport and activation of exogenous long-chain fatty
acids allows the cell to use these compounds in lipid biosyn-
thesis, protein acylation, organellar biogenesis, and energy pro-
duction. The mechanisms underlying this process appear to be
complex and involve a combination of diffusion (transmem-
brane flip) and specific membrane-bound proteins and fatty
acid-activating enzymes. It is clear that one fundamental mech-
anism that is operational in most cell types is vectorial acyla-
tion. Long-chain fatty acid transport is highly regulated and
linked to downstream metabolism and, at least in the case of
gram-negative bacteria, the energized state of the cell. We are
now confronted with the challenge of defining how these spe-
cific membrane-bound and membrane-associated proteins
function in concert to facilitate the specific and regulated
transport of long-chain fatty acids using well-defined genetic
model systems.
Long-Chain Fatty Acid Transport and Activation in
Bacteria: Implications in Early States of Infection
The genes required for acquisition of long-chain fatty acids
in E. coli are regulated at the level of transcription (46, 49).
Under high-nutrient conditions, the genes required for fatty
acid transport, activation, and -oxidation are repressed by the
global transcription factor FadR. When the cell encounters
long-chain fatty acids, FadL and FACS function to transport
and activate these compounds into intracellular pools of long-
chain acyl-CoA. These compounds represent the effectors that,
when present at sufficiently high intracellular concentrations,
bind to FadR, resulting in the derepression of the genes in-
volved in fatty acid transport, activation, and -oxidation. This
initiates a cascade of events that allow the cell to utilize long-
chain fatty acids as a carbon and energy source. DNase 1
footprinting has identified two FadR binding sites for both the
fadL (encoding the transporter) and fadD (encoding FACS)
genes (23, 45). Both the fadL and fadD genes are normally
expressed at basal levels under high-nutrient growth condi-
tions. In the presence of long-chain fatty acids as the primary
carbon source, these two genes become induced two- to three-
fold (45, 49). In addition to being regulated through long-chain
fatty acyl-CoA–FadR-mediated process, the fadL gene is reg-
ulated in response to changes in osmolarity through OmpR
while the fadD gene is also regulated by catabolite repression
through cyclic AMP (cAMP)-cAMP receptor protein (49).
These multiple levels of transcriptional regulation of fadL and
fadD must be necessary for the cell, given the physiological
consequences of high levels of long-chain fatty acyl-CoA. In
addition to regulation at the level of transcription, FACS is
apparently regulated at both the levels of translational initia-
tion (23) and membrane association (137). The long-chain
fatty acid transport system is also responsive to the energized
state of the cell, adding yet another dimension of regulation
(11).
Given the multiple levels of regulation, which we have de-
fined for the long-chain fatty acid transport system in E. coli,
one might question why such a system has evolved. The answer
must lie in the opportunistic nature of these organisms. The
FIG. 9. Patterns of C1-BODIPY-C12 uptake in wild-type, faa1,
faa4 and faa1 faa4 cells of S. cerevisiae. Reprinted from reference
54 with permission.
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outer membrane of E. coli and other gram-negative bacteria
has an outer leaflet of lipopolysaccharide, which renders it
refractory toward hydrophobic compounds (including long-
chain fatty acids). Long-chain fatty acids represent important
sources of metabolic energy and carbon for macromolecular
synthesis and therefore must be specifically and efficiently
transported across the cell envelope. Since FadL and FACS
are present at basal levels under nutrient-rich conditions, they
can function to specifically transport and activate long-chain
fatty acids when they are encountered in the environment.
Under conditions where high levels of long-chain fatty acids
are encountered in the environment, there is a specific induc-
tion of the fatty acid transport apparatus, which occurs by way
of long-chain fatty acyl-CoA–FadR-mediated derepression of
the fadL and fadD genes.
The transport of long-chain fatty acids in gram-negative
bacteria also appears to have pathophysiological implications.
Using in vivo expression technology, Mahan et al. have shown
that the fadB gene is specifically induced during early infection
of mice by Salmonella enterica serovar Typhimurium (98). The
fadB gene is part of the fadBA operon, which encodes the
-oxidation multienzyme complex. The expression of the genes
involved in -oxidation of long-chain fatty acids (including
fadBA) is controlled at the level of transcription by FadR in
response to intracellular long-chain fatty acyl-CoA. High-level
expression of FadL and FACS is dependent on FadR-medi-
ated transcriptional control. The finding that fadB is induced
implies that the intracellular levels of long-chain fatty acyl-
CoA rise, which must necessarily be the result of the concerted
activity of FadL and FACS in the transport and activation of
exogenous long-chain fatty acids. High concentrations of long-
chain fatty acids, including arachidonate, are found in the
extracellular inflammatory milieu as the result of phagocytosis
and the action of specific classes of phospholipases. The trans-
port, activation, and -oxidation of long-chain fatty acids such
as arachidonic acid by gram-negative bacteria would be pre-
dicted to result in the suppression of a local inflammatory
response. This may provide the cells with an advantage during
the early stages of colonization as well as with a means of
detoxification of high concentrations of long-chain fatty acids
that may be encountered under such conditions. Therefore,
expression of fadB along with the other fatty acid transport,
activation, and degradative genes may contribute to the me-
tabolism of bactericidal or proinflammatory host fatty acids.
There is emerging evidence that the FACS FadD and exoge-
nous fatty acids also function in HilA-dependent activation of
FIG. 10. Coimmunoprecipitation of Fat1p and Faa1p or Faa4p indicate Fat1p and a cognate FACS form a functional complex at the plasma
membrane. (A) Anti-T7 antibody (-T7) was used to pull down full-length T7Fatlp in extracts prepared from cells coexpressing T7Fatlp and
V5Faa1p or V5Faa4p as indicated. The proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and subsequent
Western blots were probed with anti-V5 (-V5) antibody to detect V5Faa1p or V5Faa4p as shown. (B) Similarly, anti-V5 was used as the
precipitating antibody to pull down V5Faa1p or V5Faa4p following coexpression of T7Fat1p and V5Faa1p or V5Faa4p, and the resultant blot was
probed with anti-T7. IP, immunoprecipitating antibody; IB, antibody used in the immunoblot. Lanes: T, total-cell extract; IP, samples immuno-
precipitated with the indicated antibody; Beads, protein A-Sepharose alone without an immunoprecipitating antibody. Anti-Pma1p was used as a
control protein specific to a yeast plasma membrane protein but unrelated to Fat1p, Faa1p or Faa4p. Reprinted from reference 141 with
permission.
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the expression of S. enterica serovar Typhimurium invasion
genes. A Tn 5 insertion was identified in the fadD gene, which
reduced the expression of hilA. These data suggest that hilA is
regulated by a FadD-dependent, FadR-independent mecha-
nism, suggesting that fatty acid derivatives may act as intracel-
lular signals to regulate hilA expression (96). Work from Spec-
tor’s laboratory also suggests the involvement of exogenous
fatty acids in S. enterica serovar Typhimurium, particularly as
related to the starvation stress response. Three carbon starva-
tion-inducible lacZ fusions were identified in the fadF gene,
which encodes an acyl-CoA dehydrogenase specific for medi-
um- and long-chain fatty acids (118), suggesting that fatty acid
trafficking in bacteria changes on initiation of the starvation
stress response. It is not yet known whether this also translates
into changes in fatty acid transport and/or activation.
A present challenge is to define the mechanism by which
FadL and FACS interact to facilitate transport. If the hypoth-
esis that FACS partitions into the inner membrane in response
to fatty acid ligands is correct, part of the challenge is to define
how FadL delivers fatty acids to the inner membrane and how
this signal facilitates membrane association. Given the patho-
physiological implications of fatty acid metabolism in entero-
toxigenic gram-negative bacteria noted above, an additional
challenge is to define whether this process provides cells with
a protective advantage during early stages of inflammation.
Fatty Acid Transport and Trafficking in Yeast
In yeast, long-chain fatty acids imported by Fat1p are con-
verted to CoA thioesters by the FACSs Faa1p or Faa4p (54,
55). The long-chain fatty acyl-CoAs are incorporated into
phospholipids, used as a substrate in protein acylation and as
carbon and energy sources. Intracellular long-chain acyl-CoAs
are presumed to bind to acyl-CoA binding protein (ACBP),
which acts to buffer the cell from the detergent properties of
these compounds as well as providing a means of intracellular
targeting (116). While this scheme of fatty acid trafficking
appears to be reasonably simple, there are a number of unan-
swered questions. For example, we do not yet understand the
precise roles of the activating enzymes Faa1p and Faa4p. Are
they essentially redundant, or are they differentially compart-
mentalized or expressed? ACBP is presumed to function as a
long-chain fatty acyl-CoA pool former, but can this protein
also target these compounds to specific sites of utilization?
Lastly, it is possible that other proteins interact with ACBP or
bind long-chain fatty acyl-CoA directly to specify intracellular
targeting.
-Oxidation of long-chain fatty acids occurs exclusively in
the peroxisomes of yeast (73). Growth of yeast in the presence
of long-chain fatty acids induces the proliferation of peroxi-
somes and results in the activation of genes whose protein
products are involved in -oxidation (73). For example, the
POX1 gene (encoding fatty acid oxidase) and the POX2 and
POX3 genes (encoding a multifunctional enzyme complex
made up of a trifunctional polypeptide subunit and a subunit
with thiolase activity) are specifically induced in the presence
of long-chain fatty acids. Therefore, these compounds or a
derivative thereof must signal the transcriptional apparatus to
specifically induce genes required for peroxisomal prolifera-
tion and -oxidation. On the other hand, growth in the pres-
ence of long-chain fatty acid oleate results in the repression of
OLE1, encoding fatty acid desaturase. In this regard, the in-
tracellular trafficking of these compounds must be highly reg-
ulated to maintain cellular homeostasis.
On the basis of work identifying Fat1p as a fatty acid trans-
porter and work demonstrating that Faa1p and Faa4p are
involved in the activation of exogenous long-chain fatty acids,
there must be a flow of long-chain fatty acid metabolites pro-
ceeding from Fat1p at the plasma membrane to intracellular
sites of metabolic utilization. If this is the case, ACBP must
play a pivotal role in regulating the flux of long-chain fatty
acyl-CoA within the cell. In fact, work from Knudsen’s labo-
ratory demonstrated that the disruption of the ACBP struc-
tural gene (ACB1) alters acyl-CoA metabolism (116). The cur-
rent challenge is to define how these different proteins function
in the flow of these fatty acid metabolites proceeding from
transport and activation. Central to this is understanding (i)
how Fat1p, Faa1p, and Faa4p function to transport and acti-
vate long-chain fatty acids and (ii) whether ACBP is specifi-
cally involved in intracellular targeting. At the level of the
peroxisome, certain details of long-chain fatty acid targeting
are now starting to be resolved. For example, two independent
pathways describing long-chain fatty acid transport across the
peroxisomal membrane have been defined (73). The first is
specific for long-chain fatty acyl-CoAs and requires Pat1p
(Pxa2p) and Pat2p (Pxa1p). The second is specific for medium-
chain fatty acids, requires the fatty acyl-CoA synthetase Faa2p,
and is apparently independent of Pat1p and Pat2p. Pat1p and
Pat2p were initially identified as peroxisomal integral mem-
brane proteins, each of which has six or seven predicted trans-
membrane domains and an ATP binding cassette (ABC) char-
acteristic of ATP binding protein transporters. These two
proteins have sequence similarities to the protein product of
the human adrenoleukodystrophy gene (ABCD1) and three
FIG. 11. Vectorial acylation in yeast. Cartoon showing the interac-
tion between Fat1p and FACS (either Faa1p or Faa4p), which function
to promote the coupled transport and activation of exogenous fatty
acids. Fatty acids (FA) partition into the plasma membrane and flip
between the membrane surfaces. It is unclear whether Fat1p enhances
this process. Fat1p (illustrated as a dimer within the membrane) and a
cognate FACS (illustrated as a dimer) form a complex, which functions
to abstract the fatty acid from the membrane concomitant with ester-
ification to CoA thioesters (FA-CoA) for further metabolism.
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related peroxisomal ABC half-transporters (ABCD2 to
ABCD4). Deletion of either Pat1p or Pat2p impairs the growth
of yeast on the long-chain fatty acids palmitate and oleate but
not myristate. The conclusion that these two proteins are in-
volved in fatty acid transport into the peroxisome is based on
studies showing that a deletion of either gene reduces -oxi-
dation of whole cells but not of cell extracts (73). A third
putative peroxisomal fatty acid transporter, Fat2p (Psc60p),
has been cloned by reverse genetics by selection for peroxiso-
mal proteins induced by oleic acid (30). Although no func-
tional studies of Fat2p have been reported, we have found that
this protein has 23% amino acid identity and 45% amino acid
similarity to Fat1p (C. C. DiRusso and P. N. Black, unpub-
lished data). Like Fat1p, Fat2p contains a presumptive ATP-
AMP signature motif characteristic of the enzymes, which form
adenylated intermediates as part of their catalytic cycle (in-
cluding the FACSs) (30). Yet, unlike these enzymes, Fat2p has
no measurable FACS activity. Deletion of Fat2p has no appar-
ent effect on peroxisomal induction and proliferation or -ox-
idation of long-chain fatty acids, which indicates either that the
protein is not required for these functions or that there is an
additional protein(s) that serves the same function.
Lessons Applied to Mammalian Systems
The studies using the bacterial and yeast model systems to
investigate the process of fatty acid transport can be directly
applied to understanding related processes in mammalian sys-
tems. It is apparent that in both bacteria and yeast, fatty acid
transport occurs by a process that links transport with activa-
tion to CoA thioesters. This process promotes efficiency in the
delivery of fatty acids to intracellular sites of utilization (in-
cluding lipid synthesis, -oxidation, and transcriptional con-
trol).
In mammalian systems, this process is likely to be more
complex, in part due to the presence of other putative fatty
acid transport proteins (e.g., FATP, FAT-CD36, and FABPpm)
and intracellular fatty acid binding proteins. In addition, there
are multiple isoforms of both FATP and FACS, which provides
additional complexity to the process. While the relationships
between the FATP isoforms and FAT-CD36 and FABPpm
have not yet been defined, is seems likely that a number of
FATP isoforms may work in conjunction with a cognate FACS
to facilitate the coupled fatty acid import-activation process. In
the context of intracellular fatty acid homeostasis, this may
function in membrane lipid turnover or complex lipid synthe-
sis. Other evidence showing differential distribution suggests
more specific roles for the different FATP isoforms, perhaps in
either tissue specificity, developmental specificity, or substrate
specificity. The finding that mmFATP1 functions in yeast sug-
gests that this model system is ideally poised to allow us to
more completely understand the process of fatty acid transport
in eukaryotic systems and the process of vectorial esterification
as a fundamental biochemical mechanism, promoting fatty acid
transport.
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